0       0

NACCT 2017


FRI130a - Platform Session I Abstracts #1-8


Oct 13, 2017 1:30pm ‐ Oct 13, 2017 3:30pm


Credits: None available.

Description

Jenn M LeRoy, MD
Effect of methylene blue on mortality in a porcine model of amlodipine toxicity
Learning Objective:

  1. Understand the mechanism of amlodipine toxicity and describe potential treatment options based on mechanism

Kaitlyn Brown, PharmD
A regional poison control center’s role in the public health response to multiple harmful algal blooms
Learning Objectives:

  1. Describe the role poison control centers have in responding to public health concerns associated with harmful algal blooms

Patrick Ng, MD
Efficacy of intramuscular cobinamide in a swine model of severe hydrogen sulfide poisoning: a prospective trial
Learning Objective:

  1. Discuss the causes of hydrogen sulfide toxicity
  2. Dicuss the role of cobinamide in sulfide poisoning

Neeraj Chhabra, MD
Graft Failure Rates of Organs Transplanted from Poisoned Patients Compared to Other Causes
Learning Objective:

  1. Compare and contrast graft failure rates for organ procured from poisoned patients compared to other causes of death

Michael Lynch, MD
Passive Poison Center Exposure Identification Using the Electronic Medical Record
Learning Objectives:

  1. Describe the process and results from one poison center's experience using the electronic medical record
  2. to identify, document, and follow poison exposure cases
  3. Identify potential areas for improved data collection by poison centers

Victoria Anderson, MPH
Early FabAV Treatment Improves Time to Full Limb Function Recovery in Patients with Copperhead Envenomation
Learning Objective:

  1. Understand how time to treatment with FabAV affected recovery in patients with copperhead envenomation 

Lauren Klein, MD
A Randomized Trial of Intramuscular Olanzapine versus Oral Clonidine for Symptomatic Treatment of Opioid Withdrawal in the Emergency Department
Learning Objectives:

  1. Discuss the comparative efficacy of olanzapine versus clonidine in the treatment of symptomatic opioid withdrawal
  2. Discuss the comparative safety concerns of olanzapine versus clonidine in the treatment of symptomatic opioid withdrawal

Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content